CONCORD, N.H. (AP) — Four people in New Hampshire have been diagnosed with fungal meningitis amid an outbreak that has led to 15 deaths and nearly 200 illnesses nationally, health officials said yesterday.
The New Hampshire cases involve three men and one woman, all between the ages of 40 and 60, officials said. All of those affected are under care and are being monitored.
The cases are related to the nationwide fungal meningitis outbreak, which has been linked to a steroid medication produced by the New England Compounding Center in Framingham, Mass., according to WMUR-TV.
“This has been a very difficult time for patients and health care providers affected by this outbreak,” said New Hampshire’s public health director, Dr. José Montero. “Our thoughts are with these patients and their families as they deal with the complicated circumstances surrounding this unfortunate incident.”
In New Hampshire, the medication believed to be related to the outbreak was distributed to Pain Care LLC’s locations in Somersworth, Merrimack and Newington.
The Centers for Disease Control and Prevention said fungal meningitis cases have been recorded in 13 states besides New Hampshire. They are Florida, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, New Jersey, North Carolina, Ohio, Tennessee, Texas and Virginia.
New England Compounding Center has voluntarily recalled all products it produced since January. However, all cases so far have resulted after injections with products from the original three lots of recalled medication.